Interstellar Extinction Law toward the Galactic Center II: V, J, H, and Ks Bands

We have determined the ratios of total to selective extinction directly from observations in the optical V band and near-infrared J band toward the Galactic center. The OGLE (Optical Gravitational Lensing Experiment) Galactic bulge fields have been observed with the SIRIUS camera on the IRSF telescope, and we obtain A(V)/E(V-J)=1.251+-0.014 and A(J)/E(V-J)=0.225+-0.007. From these ratios, we have derived A(J)/A(V) = 0.188+-0.005; if we combine A(J)/A(V) with the near-infrared extinction ratios obtained by Nishiyama et al. for more reddened fields near the Galactic center, we get A(V) : A(J) : A(H) : A(Ks) = 1 : 0.188 : 0.108 : 0.062, which implies steeply declining extinction toward the longer wavelengths. In particular, it is striking that the Ks band extinction is \approx 1/16 of the visual extinction A(V) much smaller than one tenth of A(V) so far employed.Comment: 8 pages, 7 figures, Accepted for publication in Ap

Characterization of wheat Bell1-type homeobox genes in floral organs of alloplasmic lines with Aegilops crassa cytoplasm

<p>Abstract</p> <p>Background</p> <p>Alloplasmic wheat lines with <it>Aegilops crassa </it>cytoplasm often show homeotic conversion of stamens into pistils under long-day conditions. In the pistillody-exhibiting florets, an ectopic ovule is formed within the transformed stamens, and female sterility is also observed because of abnormal integument development.</p> <p>Results</p> <p>In this study, four wheat <it>Bell1</it>-like homeobox (<it>BLH</it>) genes were isolated and named <it>WBLH1 </it>to <it>WBLH4</it>. <it>WBLH1</it>/<it>WBLH3</it>/<it>WBLH4 </it>expression was observed in the basal boundary region of the ovary in both normal pistils and transformed stamens. <it>WBLH2 </it>was also strongly expressed in integuments not only of normal ovules in pistils but also of the ectopic ovules in transformed stamens, and the <it>WBLH2 </it>expression pattern in the sterile pistils seemed to be identical to that in normal ovules of fertile pistils. In addition, WBLH1 and WBLH3 showed interactions with the three wheat KNOX proteins through the BEL domain. WBLH2, however, formed a complex with wheat KNOTTED1 and ROUGH SHEATH1 orthologs through SKY and BEL domains, but not with a wheat LIGULELESS4 ortholog.</p> <p>Conclusions</p> <p>Expression of the four <it>WBLH </it>genes is evident in reproductive organs including pistils and transformed stamens and is independent from female sterility in alloplasmic wheat lines with <it>Ae. crassa </it>cytoplasm. KNOX-BLH interaction was conserved among various plant species, indicating the significance of KNOX-BLH complex formation in wheat developmental processes. The functional features of <it>WBLH2 </it>are likely to be distinct from other <it>BLH </it>gene functions in wheat development.</p

A Chain of Dark Clouds in Projection Against the Galactic Center

In the J, H, and Ks bands survey of the the Galactic Center region over an area of 2deg x 5deg, we have found many dark clouds, among which a distinguished chain of dark clouds can be identified with a quiescent CO cloud. The distances of the clouds is estimated to be 3.2-4.2 kpc, corresponding to the Norma arm by our new method to determine distance to dark clouds using the cumulative number of stars against J-Ks colors. Adopting these estimated distances, the size is about 70 pc in length and the total mass of the cloud is 6x10^4 M_solar. Three compact HII regions harbor in the cloud, indicating that star forming activities are going on at the cores of the quiescent CO cloud on the spiral arm.Comment: 13 pages, 7 figures, accepted for publication in PAS

Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution

The version of record of this article, first published in International Journal of Clinical Oncology, is available online at Publisher’s website: https://doi.org/10.1007/s10147-024-02526-y.Urothelial carcinoma presents significant treatment challenges, especially in advanced stages. Traditionally managed with platinum-based chemotherapy, the advent of immunotherapies, particularly immune checkpoint inhibitors, has revolutionized urothelial carcinoma treatment. This review explores the evolution of urothelial carcinoma management, focusing on the transition from immune checkpoint inhibitors monotherapy to innovative combination therapies. Pembrolizumab, following the KEYNOTE-045 trial, emerged as a pivotal ICI in pretreated metastatic urothelial carcinoma, outperforming traditional chemotherapy. However, limitations surfaced in untreated metastatic urothelial carcinoma patients, particularly in those with low PD-L1 expression, as evidenced by trials like IMvigor130 and KEYNOTE-361. These challenges led to the exploration of combination therapies, including immune checkpoint inhibitors with platinum-based chemotherapy, tyrosine kinase inhibitors, and antibody–drug conjugates. Notably, the CheckMate 901 trial demonstrated improved outcomes with a nivolumab–chemotherapy combination. A significant breakthrough was achieved with the combination of enfortumab vedotin, an antibody–drug conjugates, and pembrolizumab, setting a new standard in first-line treatment for locally advanced or metastatic urothelial carcinoma. Future directions involve further exploration of antibody–drug conjugates and immune checkpoint inhibitors, as seen in the TROPHY-U-01 and TROPiCS-4 trials. The review concludes that the locally advanced or metastatic urothelial carcinoma treatment landscape is rapidly evolving, with combination therapies offering promising avenues for improved patient outcomes, signaling a new era in urothelial carcinoma management

New Classes of the Greedy-Applicable Arm Feature Distributions in the Sparse Linear Bandit Problem

We consider the sparse contextual bandit problem where arm feature affects reward through the inner product of sparse parameters. Recent studies have developed sparsity-agnostic algorithms based on the greedy arm selection policy. However, the analysis of these algorithms requires strong assumptions on the arm feature distribution to ensure that the greedily selected samples are sufficiently diverse; One of the most common assumptions, relaxed symmetry, imposes approximate origin-symmetry on the distribution, which cannot allow distributions that has origin-asymmetric support. In this paper, we show that the greedy algorithm is applicable to a wider range of the arm feature distributions from two aspects. Firstly, we show that a mixture distribution that has a greedy-applicable component is also greedy-applicable. Second, we propose new distribution classes, related to Gaussian mixture, discrete, and radial distribution, for which the sample diversity is guaranteed. The proposed classes can describe distributions with origin-asymmetric support and, in conjunction with the first claim, provide theoretical guarantees of the greedy policy for a very wide range of the arm feature distributions.Comment: Accepted by AAAI 202

Dog erythrocyte rosette-forming lymphocyte: blockage by OKT11 monoclonal antibody.

Human peripheral blood mononuclear cells (PBM) were separated into sheep erythrocyte rosette-forming (Es+) and non Es+ cells by the Ficoll-Hypaque gradient sedimentation method. Thirty-eight percent of the Es+ cells formed rosettes with dog erythrocytes and were designated as Es+Ed+ cells. The remaining Es+ cells were designated as Es+Ed- cells. Only a few non Es+ cells formed rosettes with dog erythrocytes. Among Es+Ed+ cells, T4 antigen-positive cells were observed approximately 1.7 times as often as T8 antigen-positive cells, when measured by staining with OKT4 or OKT8 monoclonal antibody. Among Es+Ed- cells, however, T4 and T8 antigen-positive cells were observed in almost equal proportion. Preincubation of PBM with OKT11 monoclonal antibody, but not with OKT4 monoclonal antibody, inhibited the rosette formation with dog as well as sheep erythrocytes. These results indicated that Es+Ed+ cells were a subpopulation of T-cells in which a majority of the cells were T4 antigen-positive, and that the binding sites of dog erythrocytes on human T-cells was closely linked with that of sheep erythrocytes.</p

Serum and urinary ferritin levels in patients with rheumatoid arthritis

The serum and urinary ferritin levels in 52 RA patients were measured by the 2-site immunoradiometric assay method. Serum ferritin levels in RA patients correlated with C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) but not with serum iron levels and hemoglobin concentrations, although they were within the normal range. High serum ferritin levels were associated with sera with hyper gamma-globulin and rheumatoid factors. In sequential studies, serum ferritin changed in parallel with ESR, CRP and disease activity in a majority of the patients. The urinary ferritin levels and u/s ratios in some RA patients were higher than control values. Higher values were found particularly in the group of patients under gold therapy but not in groups under other treatments.</p

Macroscopic quantum tunneling in a d-wave high-Tc superconductor

There is a wide recognition that Josephson-junction-like structures intrinsic to the layered cuprate high temperature superconductors offer an attractive stage for exploiting possible applications to new quantum technologies. On the other hand the low energy quasiparticle excitations characteristically present in these d-wave superconductors may easily destruct the coherence required. Here we demonstrate for the first time the feasibility of macroscopic quantum tunneling in the intrinsic Josephson junctions of a high temperature superconductor, and find it to be characterized by a high classic-to-quantum crossover temperature and a relatively weak quasiparticle dissipation.Comment: 4 pages, 3 figures, Ver. 2, Added referenc

The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab

The version of record of this article, first published in Clinical and Experimental Medicine, is available online at Publisher’s website: https://doi.org/10.1007/s10238-024-01370-8.Although immune checkpoint inhibitors (ICIs) have gained approval for metastatic renal cell carcinoma (mRCC), the response rate is still limited. Therefore, it is urgent to explore novel markers of responses to ICIs that can help assess clinical benefits. Recently, it has been noted that peripheral blood eosinophil counts are an independent factor correlated with clinical outcome of ICIs in some types of cancer. We investigated peripheral blood absolute eosinophil counts (AECs) at baseline and 4 weeks after the initiation of nivolumab for mRCC patients between February 2016 and May 2022. In addition, we examined clinicopathological features including irAEs and analyzed the correlation between AECs and clinical efficacy of nivolumab. The median progression-free survival (PFS) and overall survival (OS) for all patients were 5.7 and 25.5 months, respectively. The median AECs in patients with irAEs were significantly higher at baseline and 4 weeks after the treatment compared to those without irAEs (p < 0.001 and p = 0.001). With the cutoff value of AECs of 329 cells/µL at 4 weeks after the treatment for prediction of irAEs, high-AECs groups had significantly higher number of responders compared with that in low-AECs group (p < 0.001). Accordingly, the PFS and OS were significantly better in patients with high-AECs group than those in low-AECs group (p = 0.03 and p = 0.009). High-AECs at 4 weeks after the treatment serve as the prominent surrogate marker associated with the incidence of irAEs and better clinical outcome in mRCC patients receiving nivolumab